Predict your next investment

Corporation
CONSUMER PRODUCTS & SERVICES | Tobacco
bat.com

See what CB Insights has to offer

Investments

1

Partners & Customers

7

About British American Tobacco

British American Tobacco (LSE: BATS) (NYSE: BTI) (JSE: BTI) is a tobacco group, with brands sold in more than 200 markets.

British American Tobacco Headquarter Location

Globe House 4 Temple Place

London, England, WC2R 2PG,

United Kingdom

+44 (0) 20 7845 1000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing British American Tobacco

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find British American Tobacco in 1 Expert Collection, including Infectious Disease.

I

Infectious Disease

2,225 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

Latest British American Tobacco News

Asian Cigarette Market Report 2021-2025 Featuring China Tobacco International, ITC, Imperial Tobacco, Japan Tobacco Int'l, Philip Morris, & British American Tobacco

Oct 14, 2021

Asian cigarette market is forecasted to reach US$617.40 billion in 2025, experiencing growth at a CAGR of 5.61% Growth in the Asian cigarette market by value was due to increase in youth population, increase in female smokers and the increase in the stress level experienced by the people encouraging more people to smoke, inflation and the increase in gross domestic income driving the prices of the cigarettes thereby increasing the cigarette market value. However, the market growth would be challenged by increasing penetration of illicit cigarette, next generation products and decreasing number of habitual smokers. Asian cigarette market by volume is forecasted to reach 2.99 trillion in 2025, experiencing a decline during the period spanning from 2021 to 2025. Decline in the Asian cigarette market by volume was due to increasing awareness of the health issues which are driving people to reduce the consumption, rise in number of alternate products like NGP, increase in the awareness through education system, and increase in the prices of the cigarette. The market is anticipated to experience certain trends like increasing preference of flavored cigarettes and increase in advertising campaigns. In 2020, the dominant share of market was held by China followed by Indonesia, Japan, India, Korea, Philippines, Malaysia and Rest of Asia. Scope of the report The report provides a comprehensive analysis of the Asian cigarette market with potential impact of COVID-19. The major regional markets (China, Indonesia, Japan, India, Korea, Philippines, Malaysia and Rest of Asia) have been analyzed. The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth. The competitive landscape of the market, along with the company profiles of leading players (China Tobacco International (HK) Company Limited, ITC, Philip Morris International, British American Tobacco, Japan Tobacco International, Imperial Tobacco) are also presented in detail. Key Topics Covered:

British American Tobacco Investments

1 Investments

British American Tobacco has made 1 investments. Their latest investment was in Organigram as part of their Corporate Minority - P2P on March 3, 2021.

CBI Logo

British American Tobacco Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/11/2021

Corporate Minority - P2P

Organigram

$175M

Yes

2

Date

3/11/2021

Round

Corporate Minority - P2P

Company

Organigram

Amount

$175M

New?

Yes

Co-Investors

Sources

2

British American Tobacco Acquisitions

15 Acquisitions

British American Tobacco acquired 15 companies. Their latest acquisition was Dryft - Nicotine Pouch Product Assets on November 03, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/3/2020

Acquired Unit

1

1/12/2018

Acquired

3

7/25/2017

$991

Acq - P2P

8

7/25/2017

Subscribe to see more

$99M

Subscribe to see more

10

5/6/2017

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/3/2020

1/12/2018

7/25/2017

7/25/2017

5/6/2017

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

Total Funding

$99M

$99M

Note

Acquired Unit

Acquired

Acq - P2P

Subscribe to see more

Subscribe to see more

Sources

1

3

8

10

10

British American Tobacco Partners & Customers

7 Partners and customers

British American Tobacco has 7 strategic partners and customers. British American Tobacco recently partnered with Lexaria Bioscience on August 8, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

8/31/2020

Vendor

Lexaria Bioscience

Canada

Comments Off on Lexaria Bioscience announces R&D agreement with British American Tobacco. Lexaria Bioscience announces R&D agreement with British American Tobacco - Grizzly Gazette

Kelowna , British Columbia -- TheNewswire -- August 31 , 2020 -- Lexaria Bioscience Corp. , a global innovator in drug delivery platforms , announces that it has entered a research and development framework agreement with British American Tobacco Limited to investigate Lexaria Bioscience Corp. 's technology for potential use in nicotine products .

3

10/27/2015

Vendor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

4/2/2015

Vendor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

8/23/2012

Vendor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

11/28/2011

Vendor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

8/31/2020

10/27/2015

4/2/2015

8/23/2012

11/28/2011

Type

Vendor

Vendor

Vendor

Vendor

Vendor

Business Partner

Lexaria Bioscience

Country

Canada

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

Comments Off on Lexaria Bioscience announces R&D agreement with British American Tobacco. Lexaria Bioscience announces R&D agreement with British American Tobacco - Grizzly Gazette

Kelowna , British Columbia -- TheNewswire -- August 31 , 2020 -- Lexaria Bioscience Corp. , a global innovator in drug delivery platforms , announces that it has entered a research and development framework agreement with British American Tobacco Limited to investigate Lexaria Bioscience Corp. 's technology for potential use in nicotine products .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

British American Tobacco Team

11 Team Members

British American Tobacco has 11 team members, including former Chief Executive Officer, James Michael Lafferty.

Name

Work History

Title

Status

James Michael Lafferty

Chief Executive Officer

Former

Mattia D Alessandro

Walgreens Boots Alliance, and Procter & Gamble

Chief Financial Officer

Former

Ricardo Perdigao

Chief Financial Officer, Chief Information Officer

Former

Nick Giannakakis

Compagnie Financiere Richemont, Coca-Cola Hellenic Bottling Company, and SAP

Chief Technology Officer

Former

Peter Brickley

Chief Information Officer

Former

Name

James Michael Lafferty

Mattia D Alessandro

Ricardo Perdigao

Nick Giannakakis

Peter Brickley

Work History

Walgreens Boots Alliance, and Procter & Gamble

Compagnie Financiere Richemont, Coca-Cola Hellenic Bottling Company, and SAP

Title

Chief Executive Officer

Chief Financial Officer

Chief Financial Officer, Chief Information Officer

Chief Technology Officer

Chief Information Officer

Status

Former

Former

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.